Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Nami Yamashita, Ph.D., M.D.

Title
Institution
Department
Address
Phone

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Li W, Zhang N, Jin C, Long MD, Rajabi H, Yasumizu Y, Fushimi A, Yamashita N, Hagiwara M, Zheng R, Wang J, Kui L, Singh H, Kharbanda S, Hu Q, Liu S, Kufe D. MUC1-C drives stemness in progression of colitis to colorectal cancer. JCI Insight. 2020 Jun 18; 5(12). PMID: 32427590.
    Citations:    
  2. Shimoi T, Nagai SE, Yoshinami T, Takahashi M, Arioka H, Ishihara M, Kikawa Y, Koizumi K, Kondo N, Sagara Y, Takada M, Takano T, Tsurutani J, Naito Y, Nakamura R, Hattori M, Hara F, Hayashi N, Mizuno T, Miyashita M, Yamashita N, Yamanaka T, Saji S, Iwata H, Toyama T. The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition. Breast Cancer. 2020 May; 27(3):322-331. PMID: 32240526.
    Citations:    
  3. Yasumizu Y, Rajabi H, Jin C, Hata T, Pitroda S, Long MD, Hagiwara M, Li W, Hu Q, Liu S, Yamashita N, Fushimi A, Kui L, Samur M, Yamamoto M, Zhang Y, Zhang N, Hong D, Maeda T, Kosaka T, Wong KK, Oya M, Kufe D. Author Correction: MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer. Nat Commun. 2020 Feb 24; 11(1):1095. PMID: 32094369.
    Citations:    
  4. Yasumizu Y, Rajabi H, Jin C, Hata T, Pitroda S, Long MD, Hagiwara M, Li W, Hu Q, Liu S, Yamashita N, Fushimi A, Kui L, Samur M, Yamamoto M, Zhang Y, Zhang N, Hong D, Maeda T, Kosaka T, Wong KK, Oya M, Kufe D. MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer. Nat Commun. 2020 01 17; 11(1):338. PMID: 31953400.
    Citations:    
  5. Maehara Y, Soejima Y, Yoshizumi T, Kawahara N, Oki E, Saeki H, Akahoshi T, Ikegami T, Yamashita YI, Furuyama T, Sugimachi K, Harada N, Tagawa T, Harimoto N, Itoh S, Sonoda H, Ando K, Nakashima Y, Nagao Y, Yamashita N, Kasagi Y, Yukaya T, Kurihara T, Tsutsumi R, Takamori S, Sasaki S, Ikeda T, Yonemitsu Y, Fukuhara T, Kitao H, Iimori M, Kataoka Y, Wakasa T, Suzuki M, Teraishi K, Yoshida Y, Mori M. The evolution of surgical treatment for gastrointestinal cancers. Int J Clin Oncol. 2019 Nov; 24(11):1333-1349. PMID: 31522313.
    Citations:    
  6. Hata T, Rajabi H, Takahashi H, Yasumizu Y, Li W, Jin C, Long MD, Hu Q, Liu S, Fushimi A, Yamashita N, Kui L, Hong D, Yamamoto M, Miyo M, Hiraki M, Maeda T, Suzuki Y, Samur MK, Kufe D. MUC1-C Activates the NuRD Complex to Drive Dedifferentiation of Triple-Negative Breast Cancer Cells. Cancer Res. 2019 11 15; 79(22):5711-5722. PMID: 31519689.
    Citations:    
  7. Kamitani T, Yabuuchi H, Kanemaki Y, Tozaki M, Sonomura T, Mizukoshi W, Nakata W, Shimono T, Urano M, Yamano T, Kato F, Kuchiki M, Shiraga N, Yanagita H, Katsuda E, Kataoka M, Yamaguchi K, Horikoshi T, Gomi T, Nozaki M, Shiotani M, Amano M, Saigusa H, Sadaoka S, Kamiya H, Kubo M, Yamashita N, Yamamoto H, Honda H. Corrigendum to "Effects of menstrual cycle on background parenchymal enhancement and detectability of breast cancer on dynamic contrast-enhanced breast MRI: A multicenter study of an Asian population" [Eur. J. Radiol. 110 (2019) 130-135]. Eur J Radiol. 2019 05; 114:192. PMID: 30954326.
    Citations:    
  8. Ohtani K, Ide T, Hiasa KI, Sakamoto I, Yamashita N, Kubo M, Tsutsui H. Cardioprotective effect of renin-angiotensin inhibitors and ß-blockers in trastuzumab-related cardiotoxicity. Clin Res Cardiol. 2019 Oct; 108(10):1128-1139. PMID: 30859381.
    Citations:    
  9. Shibata T, Tokunaga E, Hattori S, Watari K, Murakami Y, Yamashita N, Oki E, Itou J, Toi M, Maehara Y, Kuwano M, Ono M. Y-box binding protein YBX1 and its correlated genes as biomarkers for poor outcomes in patients with breast cancer. Oncotarget. 2018 Dec 14; 9(98):37216-37228. PMID: 30647855.
    Citations:    
  10. Kamitani T, Yabuuchi H, Kanemaki Y, Tozaki M, Sonomura T, Mizukoshi W, Nakata W, Shimono T, Urano M, Yamano T, Kato F, Kuchiki M, Shiragami N, Yanagita H, Katsuda E, Kataoka M, Yamaguchi K, Horikoshi T, Gomi T, Nozaki M, Shiotani M, Amano M, Saigusa H, Sadaoka S, Kamiya H, Kubo M, Yamashita N, Yamamoto H, Honda H. Effects of menstrual cycle on background parenchymal enhancement and detectability of breast cancer on dynamic contrast-enhanced breast MRI: A multicenter study of an Asian population. Eur J Radiol. 2019 01; 110:130-135. PMID: 30599849.
    Citations:    
  11. Takamori S, Takada K, Tagawa T, Toyokawa G, Hirai F, Yamashita N, Okamoto T, Oki E, Yoshizumi T, Oda Y, Maehara Y. Differences in PD-L1 expression on tumor and immune cells between lung metastases and corresponding primary tumors. Surg Oncol. 2018 Dec; 27(4):637-641. PMID: 30449485.
    Citations:    
  12. Inoue Y, Yamashita N, Ueo H, Tanaka K, Saeki H, Oki E, Tokunaga E, Maehara Y. The Clinical Usefulness of the LigaSure™ Small Jaw in Axillary Lymph Node Dissection in Patients with Breast Cancer. Anticancer Res. 2018 04; 38(4):2359-2362. PMID: 29599361.
    Citations:    
  13. Yamashita N, Tokunaga E, Iimori M, Inoue Y, Tanaka K, Kitao H, Saeki H, Oki E, Maehara Y. Epithelial Paradox: Clinical Significance of Coexpression of E-cadherin and Vimentin With Regard to Invasion and Metastasis of Breast Cancer. Clin Breast Cancer. 2018 10; 18(5):e1003-e1009. PMID: 29526677.
    Citations:    
  14. Inoue Y, Yamashita N, Kitao H, Tanaka K, Saeki H, Oki E, Oda Y, Tokunaga E, Maehara Y. Clinical Significance of the Wild Type p53-Induced Phosphatase 1 Expression in Invasive Breast Cancer. Clin Breast Cancer. 2018 08; 18(4):e643-e650. PMID: 29275106.
    Citations:    
  15. Noma S, Kiyohara K, Hirokado R, Yamashita N, Migita Y, Tanaka M, Furukawa S, Ogihara H, Morinaga Y, Igura N, Shimoda M. Increase in hydrophobicity of Bacillus subtilis spores by heat, hydrostatic pressure, and pressurized carbon dioxide treatments. J Biosci Bioeng. 2018 Mar; 125(3):327-332. PMID: 29107628.
    Citations:    
  16. Shoji F, Yamashita N, Inoue Y, Kozuma Y, Toyokawa G, Hirai F, Ito K, Tagawa T, Okamoto T, Maehara Y. Surgical Resection and Outcome of Synchronous and Metachronous Primary Lung Cancer in Breast Cancer Patients. Anticancer Res. 2017 10; 37(10):5871-5876. PMID: 28982914.
    Citations:    
  17. Oki E, Okano S, Saeki H, Umemoto Y, Teraishi K, Nakaji Y, Ando K, Zaitsu Y, Yamashita N, Sugiyama M, Nakashima Y, Ohgaki K, Oda Y, Maehara Y. Protein Expression of Programmed Death 1 Ligand 1 and HER2 in Gastric Carcinoma. Oncology. 2017; 93(6):387-394. PMID: 28910818.
    Citations:    
  18. Yamashita N, Tokunaga E, Yamamoto H, Shimizu C, Taketani K, Inoue Y, Saeki H, Oki E, Maehara Y. The Local Recurrence of Breast Cancer with Squamous Metaplasia and Obvious Histological Heterogeneity. Anticancer Res. 2017 09; 37(9):5249-5254. PMID: 28870961.
    Citations:    
  19. Inoue Y, Yamashita N, Tokunaga E, Tanaka K, Ueo H, Saeki H, Oki E, Yamamoto H, Maehara Y. A Locally Advanced Breast Cancer that Achieved pCR with Pertuzumab, Trastuzumab and Docetaxel: Case Report. Anticancer Res. 2017 04; 37(4):1917-1921. PMID: 28373460.
    Citations:    
  20. Tokunaga E, Yamashita N, Tanaka K, Inoue Y, Akiyoshi S, Saeki H, Oki E, Kitao H, Maehara Y. Expression of APOBEC3B mRNA in Primary Breast Cancer of Japanese Women. PLoS One. 2016; 11(12):e0168090. PMID: 27977754.
    Citations:    
  21. Sugiyama M, Oki E, Nakaji Y, Tsutsumi S, Ono N, Nakanishi R, Sugiyama M, Nakashima Y, Sonoda H, Ohgaki K, Yamashita N, Saeki H, Okano S, Kitao H, Morita M, Oda Y, Maehara Y. High expression of the Notch ligand Jagged-1 is associated with poor prognosis after surgery for colorectal cancer. Cancer Sci. 2016 Nov; 107(11):1705-1716. PMID: 27589478.
    Citations:    
  22. Nakaji Y, Oki E, Nakanishi R, Ando K, Sugiyama M, Nakashima Y, Yamashita N, Saeki H, Oda Y, Maehara Y. Prognostic value of BRAF V600E mutation and microsatellite instability in Japanese patients with sporadic colorectal cancer. J Cancer Res Clin Oncol. 2017 Jan; 143(1):151-160. PMID: 27672042.
    Citations:    
  23. Tanaka K, Tokunaga E, Yamashita N, Sagara Y, Ohi Y, Taguchi K, Ohno S, Okano S, Oda Y, Maehara Y. The relationship between the expression of FOXA1 and GATA3 and the efficacy of neoadjuvant endocrine therapy. Breast Cancer. 2017 May; 24(3):384-392. PMID: 27473079.
    Citations:    
  24. Tanaka K, Tokunaga E, Inoue Y, Yamashita N, Saeki H, Okano S, Kitao H, Oki E, Oda Y, Maehara Y. Impact of Expression of Vimentin and Axl in Breast Cancer. Clin Breast Cancer. 2016 12; 16(6):520-526.e2. PMID: 27506606.
    Citations:    
  25. Takizawa K, Yamamoto H, Taguchi K, Ohno S, Tokunaga E, Yamashita N, Kubo M, Nakamura M, Oda Y. Insulin-like growth factor II messenger RNA-binding protein-3 is an indicator of malignant phyllodes tumor of the breast. Hum Pathol. 2016 09; 55:30-8. PMID: 27137988.
    Citations:    
  26. Tokunaga E, Yamashita N, Kitao H, Tanaka K, Taketani K, Inoue Y, Saeki H, Oki E, Oda Y, Maehara Y. Biological and clinical significance of loss of heterozygosity at the INPP4B gene locus in Japanese breast cancer. Breast. 2016 Feb; 25:62-8. PMID: 26577950.
    Citations:    
  27. Yamashita N, Tokunaga E, Kitao H, Hitchins M, Inoue Y, Tanaka K, Hisamatsu Y, Taketani K, Akiyoshi S, Okada S, Oda Y, Saeki H, Oki E, Maehara Y. Epigenetic Inactivation of BRCA1 Through Promoter Hypermethylation and Its Clinical Importance in Triple-Negative Breast Cancer. Clin Breast Cancer. 2015 Dec; 15(6):498-504. PMID: 26195437.
    Citations:    
  28. Tokunaga E, Hisamatsu Y, Tanaka K, Yamashita N, Saeki H, Oki E, Kitao H, Maehara Y. Molecular mechanisms regulating the hormone sensitivity of breast cancer. Cancer Sci. 2014 Nov; 105(11):1377-83. PMID: 25155268.
    Citations:    
  29. Wang CQ, Krishnan V, Tay LS, Chin DW, Koh CP, Chooi JY, Nah GS, Du L, Jacob B, Yamashita N, Lai SK, Tan TZ, Mori S, Tanuichi I, Tergaonkar V, Ito Y, Osato M. Disruption of Runx1 and Runx3 leads to bone marrow failure and leukemia predisposition due to transcriptional and DNA repair defects. Cell Rep. 2014 Aug 07; 8(3):767-82. PMID: 25066130.
    Citations:    
  30. Tokunaga E, Okano S, Nakashima Y, Yamashita N, Tanaka K, Akiyoshi S, Taketani K, Shirouzu M, Yamamoto H, Morita M, Maehara Y. Spontaneous regression of breast cancer with axillary lymph node metastasis: a case report and review of literature. Int J Clin Exp Pathol. 2014; 7(7):4371-80. PMID: 25120822.
    Citations:    
  31. Taketani K, Tokunaga E, Yamashita N, Tanaka K, Zaitsu Y, Akiyoshi S, Okada S, Aishima S, Morita M, Maehara Y. A case of invasive micropapillary carcinoma of the breast involving extensive lymph node metastasis. World J Surg Oncol. 2014 Apr 04; 12:84. PMID: 24708742.
    Citations:    
  32. Hisamatsu Y, Tokunaga E, Yamashita N, Akiyoshi S, Okada S, Nakashima Y, Taketani K, Aishima S, Oda Y, Morita M, Maehara Y. Impact of GATA-3 and FOXA1 expression in patients with hormone receptor-positive/HER2-negative breast cancer. Breast Cancer. 2015 Sep; 22(5):520-8. PMID: 24415069.
    Citations:    
  33. Morita M, Saeki H, Ito S, Ikeda K, Yamashita N, Ando K, Hiyoshi Y, Ida S, Tokunaga E, Uchiyama H, Oki E, Ikeda T, Yoshida S, Nakashima T, Maehara Y. Technical improvement of total pharyngo-laryngo-esophagectomy for esophageal cancer and head and neck cancer. Ann Surg Oncol. 2014 May; 21(5):1671-7. PMID: 24390709.
    Citations:    
  34. Watanabe M, Uehara Y, Yamashita N, Fujimura Y, Nishio K, Sawada T, Takeda K, Koizumi F, Koh Y. Multicolor detection of rare tumor cells in blood using a novel flow cytometry-based system. Cytometry A. 2014 Mar; 85(3):206-13. PMID: 24327318.
    Citations:    
  35. Tanaka K, Tokunaga E, Yamashita N, Taketani K, Akiyoshi S, Morita M, Maehara Y. Luteinizing hormone-releasing hormone agonist plus an aromatase inhibitor as second-line endocrine therapy in premenopausal females with hormone receptor-positive metastatic breast cancer. Surg Today. 2014 Sep; 44(9):1678-84. PMID: 24218007.
    Citations:    
  36. Taketani K, Tokunaga E, Yamashita N, Tanaka K, Akiyoshi S, Okada S, Ando K, Kimura Y, Saeki H, Oki E, Morita M, Kusumoto T, Maehara Y. Early discontinuation of adjuvant hormone therapy is associated with a poor prognosis in Japanese breast cancer patients. Surg Today. 2014 Oct; 44(10):1841-6. PMID: 24142101.
    Citations:    
  37. Tokunaga E, Hisamatsu Y, Taketani K, Yamashita N, Akiyoshi S, Okada S, Tanaka K, Saeki H, Oki E, Aishima S, Oda Y, Morita M, Maehara Y. Differential impact of the expression of the androgen receptor by age in estrogen receptor-positive breast cancer. Cancer Med. 2013 Dec; 2(6):763-73. PMID: 24403250.
    Citations:    
  38. Morita M, Saeki H, Ito S, Kimura Y, Yamashita N, Ando K, Hiyoshi Y, Tokunaga E, Oki E, Ikeda T, Yoshida S, Nakashima T, Maehara Y. Surgical strategies for esophageal cancer associated with head and neck cancer. Surg Today. 2014 Sep; 44(9):1603-10. PMID: 23989943.
    Citations:    
  39. Yamashita N, Tokunaga E, Kitao H, Hisamatsu Y, Taketani K, Akiyoshi S, Okada S, Aishima S, Morita M, Maehara Y. Vimentin as a poor prognostic factor for triple-negative breast cancer. J Cancer Res Clin Oncol. 2013 May; 139(5):739-46. PMID: 23354842.
    Citations:    
  40. Tokunaga E, Nakashima Y, Yamashita N, Hisamatsu Y, Okada S, Akiyoshi S, Aishima S, Kitao H, Morita M, Maehara Y. Overexpression of metadherin/MTDH is associated with an aggressive phenotype and a poor prognosis in invasive breast cancer. Breast Cancer. 2014 May; 21(3):341-9. PMID: 22903204.
    Citations:    
  41. Morrison NA, Stephens AA, Osato M, Polly P, Tan TC, Yamashita N, Doecke JD, Pasco J, Fozzard N, Jones G, Ralston SH, Sambrook PN, Prince RL, Nicholson GC. Glutamine repeat variants in human RUNX2 associated with decreased femoral neck BMD, broadband ultrasound attenuation and target gene transactivation. PLoS One. 2012; 7(8):e42617. PMID: 22912713.
    Citations:    
  42. Nakanishi R, Kitao H, Fujinaka Y, Yamashita N, Iimori M, Tokunaga E, Yamashita N, Morita M, Kakeji Y, Maehara Y. FANCJ expression predicts the response to 5-fluorouracil-based chemotherapy in MLH1-proficient colorectal cancer. Ann Surg Oncol. 2012 Oct; 19(11):3627-35. PMID: 22526901.
    Citations:    
  43. Okada S, Tokunaga E, Kitao H, Akiyoshi S, Yamashita N, Saeki H, Oki E, Morita M, Kakeji Y, Maehara Y. Loss of heterozygosity at BRCA1 locus is significantly associated with aggressiveness and poor prognosis in breast cancer. Ann Surg Oncol. 2012 May; 19(5):1499-507. PMID: 22179631.
    Citations:    
  44. Hisamatsu Y, Tokunaga E, Yamashita N, Akiyoshi S, Okada S, Nakashima Y, Aishima S, Morita M, Kakeji Y, Maehara Y. Impact of FOXA1 expression on the prognosis of patients with hormone receptor-positive breast cancer. Ann Surg Oncol. 2012 Apr; 19(4):1145-52. PMID: 21984487.
    Citations:    
  45. Tsujimoto T, Hirai T, Kitaoka H, Hata M, Nishio K, Okuchi K, Yamashita N, Yoshida M, Fujii H, Fukui H. Secondary aortoduodenal fistula identified by ultrasonography. J Med Ultrason (2001). 2011 Jul; 38(3):161-5. PMID: 27278504.
    Citations:    
  46. Marugami N, Hirai T, Yamashita N, Yoshida M, Ohishi H, Higuchi B, Kanehiro H, Nakajima Y. Erratum to: A case of perforated multiple gastric duplication cysts with five-layered appearance on ultrasonography. J Med Ultrason (2001). 2011 Jan; 38(1):53. PMID: 27278340.
    Citations:    
  47. Tokunaga E, Okada S, Yamashita N, Akiyoshi S, Kitao H, Morita M, Kakeji Y, Maehara Y. High incidence and frequency of LOH are associated with aggressive features of high-grade HER2 and triple-negative breast cancers. Breast Cancer. 2012 Apr; 19(2):161-9. PMID: 21063923.
    Citations:    
  48. Ng CE, Yokomizo T, Yamashita N, Cirovic B, Jin H, Wen Z, Ito Y, Osato M. A Runx1 intronic enhancer marks hemogenic endothelial cells and hematopoietic stem cells. Stem Cells. 2010 Oct; 28(10):1869-81. PMID: 20799333.
    Citations:    
  49. Marugami N, Hirai T, Yamashita N, Yoshida M, Ohishi H, Higuchi B, Kanehiro H, Nagajima Y. A case of perforated multiple gastric duplication cysts with five-layered appearance on ultrasonography. J Med Ultrason (2001). 2011 Jan; 38(1):47-51. PMID: 27278339.
    Citations:    
  50. Jacob B, Osato M, Yamashita N, Wang CQ, Taniuchi I, Littman DR, Asou N, Ito Y. Stem cell exhaustion due to Runx1 deficiency is prevented by Evi5 activation in leukemogenesis. Blood. 2010 Feb 25; 115(8):1610-20. PMID: 20008790.
    Citations:    
  51. Kasagi Y, Yamazaki K, Nakashima A, Yamana T, Yamashita N, Kayashima H, Hoshino Y, Ishida M, Yoshizumi T, Sadanaga N, Fukuda A, Matsuura H, Okadome K. Chondroblastic osteosarcoma arising from the pleura: report of a case. Surg Today. 2009; 39(12):1064-7. PMID: 19997802.
    Citations:    
  52. Marugami N, Hirai T, Yamashita N, Yoshida M, Ohishi H. Ultrasonographic findings of renal arteriovenous malformations. J Med Ultrason (2001). 2009 Mar; 36(1):45-7. PMID: 27276909.
    Citations:    
  53. Okayama S, Hirai T, Yamashita N, Somekawa S, Iwano M, Uemura S, Kanauchi M, Saito Y. Contrast-enhanced ultrasonography with Sonazoid for evaluation of renal microcirculation. J Med Ultrason (2001). 2008 Dec; 35(4):183-9. PMID: 27278990.
    Citations:    
  54. Tokunaga M, Shirabe K, Yamashita N, Hiki N, Yamaguchi T. Bowel obstruction due to sciatic hernia. Dig Surg. 2008; 25(3):185-6. PMID: 18577860.
    Citations:    
  55. Motoda L, Osato M, Yamashita N, Jacob B, Chen LQ, Yanagida M, Ida H, Wee HJ, Sun AX, Taniuchi I, Littman D, Ito Y. Runx1 protects hematopoietic stem/progenitor cells from oncogenic insult. Stem Cells. 2007 Dec; 25(12):2976-86. PMID: 17823240.
    Citations:    
  56. Sakaguchi H, Tanaka T, Marugami N, Kichikawa K, Horiuchi H, Morioka C, Toyohara M, Moriya K, Nishiofuku M, Mitoro A, Fukui H, Hirai T, Yamashita N, Ouji Y, Ishizaka S, Yoshikawa M. Cystic echinococcosis in immigrant from Peru: first case treated with percutaneous treatment in Japan. Parasitol Int. 2007 Sep; 56(3):207-10. PMID: 17382581.
    Citations:    
  57. Huang L, Osato M, Yanagida M, Yamashita N, Ito Y. The myeloid features of BXH2 leukemias may result from the lack of one copy of the repetitive sequence in the long terminal repeat viral enhancer. Int J Hematol. 2007 Feb; 85(2):170-2. PMID: 17321997.
    Citations:    
  58. Yamashita N, Osato M, Huang L, Yanagida M, Kogan SC, Iwasaki M, Nakamura T, Shigesada K, Asou N, Ito Y. Haploinsufficiency of Runx1/AML1 promotes myeloid features and leukaemogenesis in BXH2 mice. Br J Haematol. 2005 Nov; 131(4):495-507. PMID: 16281942.
    Citations:    
  59. Yanagida M, Osato M, Yamashita N, Liqun H, Jacob B, Wu F, Cao X, Nakamura T, Yokomizo T, Takahashi S, Yamamoto M, Shigesada K, Ito Y. Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice. Oncogene. 2005 Jun 30; 24(28):4477-85. PMID: 15856017.
    Citations:    
  60. Inoue K, Ozaki S, Ito K, Iseda T, Kawaguchi S, Ogawa M, Bae SC, Yamashita N, Itohara S, Kudo N, Ito Y. Runx3 is essential for the target-specific axon pathfinding of trkc-expressing dorsal root ganglion neurons. Blood Cells Mol Dis. 2003 Mar-Apr; 30(2):157-60. PMID: 12732177.
    Citations:    
  61. Inoue K, Ozaki S, Shiga T, Ito K, Masuda T, Okado N, Iseda T, Kawaguchi S, Ogawa M, Bae SC, Yamashita N, Itohara S, Kudo N, Ito Y. Runx3 controls the axonal projection of proprioceptive dorsal root ganglion neurons. Nat Neurosci. 2002 Oct; 5(10):946-54. PMID: 12352981.
    Citations: 83     Fields:    Translation:AnimalsCells
  62. Li QL, Ito K, Sakakura C, Fukamachi H, Inoue Ki, Chi XZ, Lee KY, Nomura S, Lee CW, Han SB, Kim HM, Kim WJ, Yamamoto H, Yamashita N, Yano T, Ikeda T, Itohara S, Inazawa J, Abe T, Hagiwara A, Yamagishi H, Ooe A, Kaneda A, Sugimura T, Ushijima T, Bae SC, Ito Y. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell. 2002 Apr 05; 109(1):113-24. PMID: 11955451.
    Citations:    
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Yamashita's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (331)
Explore
_
Co-Authors (7)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.